| FDA announces new recall of Medtronic surgical devices over safety concerns () |
| Cardiologists make case against routine interventions for asymptomatic severe AS () |
| Plant-based diets may help patients with diabetes, heart disease live longer () |
| First comprehensive T-TEER resource examines best practices for tricuspid valve repair () |
| So far, so good: TAVR comparable to open heart surgery after 5 years in low-risk patients () |
| Oral semaglutide reduces heart risks while helping patients move past ‘fear of the needle’ () |
| ‘A practice-changing trial’: Semaglutide linked to key benefits for PAD patients with diabetes () |
| GE HealthCare launches new cardiac CT scanner with advanced AI capabilities () |
| FDA chooses not to approve new nasal spray for heart rhythm issues () |
| Challenges of Diagnosing CAD in Women () |
| ACC urges RFK Jr. to make Medicare reform a priority, warns against mass layoffs () |
| Strokes more likely for U.S. heart transplant recipients following policy change () |
| Abbott gains CE mark approval for Volt PFA system () |
| FDA sees promise in new AI model for heart attack detection () |
| A glass of orange juice a day may help keep the cardiologist away () |
| AHA still working to find more patients with severe aortic stenosis who may require care () |
| Timing is everything: Delaying noncardiac surgery after a heart procedure reduces risks () |
| The biggest names in TAVR are sharing new data at ACC.25 () |
| Is statin therapy safe for pregnant women? () |
| First-in-class SAVR valve from Edwards Lifesciences linked to positive 5-year outcomes () |
| FDA approves vutrisiran to treat ATTR-CM () |
| Abbott makes IVL move as FDA approves new clinical trial () |
| Key trends in transcatheter tricuspid valve interventions () |
| New drug shows early potential to treat aortic stenosis in some patients without TAVR, SAVR () |
| New scanners and strategies for the ‘golden age of CCTA’ () |
| Direct marketing to cardiologists increases uptake of some, but not all, heart failure drugs () |
| How to address cardiologist burnout () |
| CMS approves Medicare coverage for transcatheter tricuspid valve replacement () |
| Safety update: FDA announces Class I recall due to atherectomy devices breaking during use () |
| Choosing left radial access in the cath lab helps cardiologists limit radiation exposure () |
| TAVR for failing surgical valves: Lessons learned from new 5-year data () |
| Enabling X-ray-free ablation procedures in the EP lab () |
| The evolution of RF technology to reduce complications and improve outcomes () |
| Opportunistic screening: AI highlights key heart findings in mammography images () |
| Electrophysiology Innovation at Texas Cardiac Arrhythmia Institute () |
| Newborns with congenital heart defects face elevated cancer risk () |
| Mitral valve repair vs. replacement: Surgeons track long-term outcomes in patients with infective endocarditis () |
| Advances in bioresorbable stents show promise for treating PAD () |
| Cannabis use increases risk of heart attack, stroke in young adults () |
| The revolution is here: AI’s growing role in cardiovascular imaging, interventional cardiology () |
| FDA clears first generic versions of rivaroxaban—what it means for patient care () |
| SMART 2-year TAVR hemodynamic data: Medtronic Evolut is better compared to Edwards Sapien in small annulus patients () |
| Bracco updates HeartSee coronary flow capacity software with new diagnostic features () |
| American College of Cardiology shares new guidance focused on evaluation, management of cardiogenic shock () |
| Woman says husband’s heart condition was misdiagnosed in wrongful death lawsuit () |
| Abbott’s Amulet LAAO device linked to long-term safety, effectiveness () |
| Food insecurity increases risk of poor heart health in young adults () |
| TAVR or TAVI? Cardiologists want a single acronym for the popular heart procedure () |
| AI could help cardiologists predict bleeding, stroke risks in AFib patients on DOACs () |
| Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor () |
| TAVR in Africa linked to high success rate, but above-average risks () |
| Patient discharged with total artificial heart for first time—goes 105 days while awaiting transplant () |
| Cardiologist arrested for allegedly sexually assaulting multiple colleagues () |
| Tenecteplase compares favorably to alteplase in new comparison of FDA-approved stroke drugs () |
| Fewer heart failure patients are dying from cardiac arrest—but disparities persist () |
| Family files lawsuit after transplant ends in tragedy—says son ‘got the heart of a meth addict’ () |
| Blood tests for signs of organ rejection made available for young heart transplant patients () |
| FDA clears AI-assisted CCTA software that assesses plaques for signs of heart disease () |
| Wellstar's CCTA + Heartflow Program Impact: Improving Patient Care While Driving Financial Growth () |
| TAVR linked to stronger valve performance than SAVR in new 5-year study () |
| Cardiology groups urge Congress to ‘take a stand’ after spending proposal fails to fix Medicare cuts () |
| Self-expanding TAVR valves still linked to superior durability in patients with small annuli after 2 years () |
| ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension () |
| Cardiologists agree: Early TAVR or SAVR for asymptomatic severe AS limits strokes, hospitalizations () |
| SCAI leaders 'on a mission' to improve cath lab protection from radiation, orthopedic injury () |
| ‘A new alternative’: Tiny pacemakers for infants show early promise () |
| Deadline extended: Nominate a young cardiology professional today () |
| Cardiologists make history, complete world’s first robotic transcatheter mitral valve replacements () |
| Building a successful CCTA program: Physicians and healthcare executives to share advice () |
| FDA approves design updates for Perceval Plus surgical aortic valve () |
| Cardiologists are first in world to use new TAVR catheter from Boston Scientific () |
| FDA approves first new clot-dissolving drug for ischemic stroke in decades () |
| TAVR vs. SAVR: Real-world data highlight advantages of both techniques () |
| Cleerly and Bunkerhill Health unite in the name of AI-based cardiac imaging evaluations () |
| Cardiologists treat first commercial patients with FDA-cleared valve-in-valve TAVR device () |
| How AI and CCTA help heart teams plan ahead before PCI () |
| Shockwave Medical launches new IVL catheter for targeting challenging lesions in PAD patients () |
| Philips pulls endovascular devices from market after safety issues prompt Class I recall () |
| Boston Scientific enters renal denervation market with acquisition worth up to $540M () |
| Cardiologists recommend complete revascularization, intravascular imaging in new ACS guidelines () |
